The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...
MedPage Today on MSN1d
FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found ProblemsThe FDA has found problems at an Indian factory that makes generic drugs for American patients, including one medication that ...
Targeting final FDA approval of YUTREPIA after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil products in clinical studiesStrengthened financial positio ...
VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, ...
Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year for CytoDyn Inc. ("CytoDyn" or the "Company"). On February 24, 2025 ...
This press release aims to clarify what Arialief is, how it works, and why so many people are asking questions like "Is ...
The evolution of the safety and effectiveness evaluation of endovascular grafts intended for abdominal aortic aneurysm repair ...
The inspection was completed with no 483 observations, demonstrating total compliance with the USFDA standards.
Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback